Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Published:2017-01-10 Issue:5 Volume:23 Page:1149-1155
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Coutré Steven E.,Furman Richard R.,Flinn Ian W.,Burger Jan A.,Blum Kristie,Sharman Jeff,Jones Jeffrey,Wierda William,Zhao Weiqiang,Heerema Nyla A.,Johnson Amy J.,Tran Anh,Zhou Cathy,Bilotti Elizabeth,James Danelle F.,Byrd John C.,O'Brien Susan

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NF-kB affects migration of vascular smooth muscle cells after treatment with heparin and ibrutinib;Biochemistry and Biophysics Reports;2024-07

2. Cardiovascular side effects of signaling pathway inhibitors in chronic lymphocytic leukemia therapy;Onkologie;2023-11-29

3. Impacts of early therapy response, interval to therapy interruption, and cumulative therapy interruption duration on outcome of ibrutinib therapy in relapsed/refractory chronic lymphocytic leukemia;Annals of Hematology;2023-07-01

4. Kinase Inhibitors and Atrial Fibrillation;JACC: Clinical Electrophysiology;2023-04

5. Infectious Complications of Targeted Therapies for Solid Cancers or Leukemias/Lymphomas;Cancers;2023-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP